Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator goforthebet, BigBake1, LongRun8
Search This Board:
Last Post: 7/24/2014 4:06:48 AM - Followers: 123 - Board type: Free - Posts Today: 1

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.



CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.



ADJUVANT PIPELINE:





CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for NVAX
NVAX News: Novavax Recognized as One of The Washington Post's Top Workplaces 06/23/2014 04:11:05 PM
NVAX News: Novavax Announces Management Promotions 06/19/2014 04:26:04 PM
NVAX News: Novavax Announces Management Promotions 06/19/2014 04:10:00 PM
NVAX News: Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus 06/18/2014 04:59:53 PM
NVAX News: Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus 06/18/2014 04:40:30 PM
PostSubject
#1945   -Barrons analytics target is 9-14 STONG BUY sedrik 07/24/14 04:06:48 AM
#1944   NVAX = strong strong buying opportunity! Spread the word! BCLBCL 07/23/14 08:40:36 AM
#1943   Haha that's how much the report costs lol StickyStock 07/23/14 08:39:13 AM
#1942   http://www.reuters.com/finance/stocks/analystResearch?symbol=NVAX.O analytics t sedrik 07/23/14 06:31:46 AM
#1941   Analyst REPORT NVAX 22 JUl 2014 target $25.00 sedrik 07/23/14 06:29:30 AM
#1940   Novavax, Inc. [$NVAX] due diligence stocktrademan 07/07/14 11:08:23 AM
#1939   $5 test coming again...watch for breakout. http://stockcharts.com/h-sc/ui?s=NVAX&p=D&b=5&amp fais007 06/25/14 06:50:12 PM
#1938   It is the app, nothing like that on BigBake1 06/23/14 11:02:19 AM
#1937   Did any today noticed NvAx pps on CBNC stockwinner 06/23/14 10:39:46 AM
#1936   I initially thought something was up the last LongRun8 06/21/14 04:37:11 PM
#1935   I have two theories, either someone who tried BigBake1 06/21/14 09:41:32 AM
#1934   Maybe some good news coming in! Monday morning!! stockwinner 06/21/14 09:21:55 AM
#1933   Very interesting trading Friday. Friend told me about Ichauway 06/21/14 09:14:08 AM
#1932   wow, that was huge.. goforthebet 06/20/14 05:07:52 PM
#1931   All I know is someone bought 2,038,092 in BigBake1 06/20/14 04:01:16 PM
#1930   News? $5.02 Tate 06/20/14 03:57:52 PM
#1929   Insider purchase again, Great! MRatt 06/18/14 02:53:04 AM
#1928   that is again a good sign goforthebet 06/18/14 02:38:48 AM
#1927   More insider buying from the market: BigBake1 06/17/14 05:43:39 PM
#1926   Well the market likes the fact that not BigBake1 06/12/14 09:50:54 AM
#1925   People need to think about why they need BigBake1 06/09/14 10:11:18 AM
#1924   Well said. People who get pissed off at nypete 06/07/14 08:33:04 AM
#1923   The price is determined by the underwriters and nypete 06/07/14 08:21:08 AM
#1922   Maybe you just paid too high a price. nypete 06/07/14 08:14:24 AM
#1921   This is from the current prospectus. BigBake1 06/06/14 02:53:09 PM
#1920   All good points, Big Bake. Also, it LongRun8 06/06/14 01:14:19 PM
#1919   How else do you expect them to raise BigBake1 06/06/14 12:56:19 PM
#1918   It still screws the guys who have been Light-man 06/06/14 12:33:32 PM
#1917   Thanks - I'm long on this stock. Tate 06/06/14 12:10:31 PM
#1916   It is based upon yesterdays close minus an BigBake1 06/06/14 12:04:23 PM
#1915   The $4.00 price point looks like they have Jon32 06/06/14 11:51:08 AM
#1914   Could someone explain why $4.00? I thought it Tate 06/06/14 11:25:25 AM
#1913   It's still disappointing to see the stock offered sarshee 06/06/14 11:19:42 AM
#1912   Not really, the offering is in fact priced BigBake1 06/06/14 09:45:18 AM
#1911   Pricing the stock offering at 4.00 is a Light-man 06/05/14 09:51:10 PM
#1910   NVAX has plenty of money. Canx presentation today Tate 06/05/14 10:28:08 AM
#1909   Bottom falling out. Now that makes more sense. Light-man 06/05/14 10:01:50 AM
#1908   This is a wacky stock. A pps spike Light-man 06/05/14 08:31:56 AM
#1907   What a bummer stockwinner 06/04/14 06:28:08 PM
#1906   Need to wait for the offering price, date nypete 06/04/14 04:30:36 PM
#1905   Novavax Announces Proposed Public Offering of Common Stock LongRun8 06/04/14 04:03:36 PM
#1904   Stanley C. Erck, President and Chief Executive Officer, coinguy 06/04/14 08:25:34 AM
#1903   After-hours bid is $4.81, with ask of $4.90 Jon32 06/03/14 06:27:53 PM
#1902   It is showing 3.2 million shares sold after-hours Jon32 06/03/14 06:25:03 PM
#1901   What happen at the close today? Around 3.5 coinguy 06/03/14 04:20:42 PM
#1900   Nice seeing it going in the right direction goforthebet 05/28/14 03:28:25 AM
#1899   Will we see the $6.50 again soon stockwinner 05/23/14 08:32:41 PM
#1898   NVAX Ichauway 05/23/14 07:59:12 PM
#1897   Yea, I put in a limit buy at paladin551 05/23/14 03:15:30 PM
#1896   It has a big upside to it either Bill de MT 05/23/14 03:10:26 PM
PostSubject